Study to Evaluate Efficacy, Safety and Immunogenicity of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ) Vaccine GSK1437173A in Adults Aged 70 Years and Older
Clinical trial NCT01165229 · COMPLETED
Trial details
- NCT number
- NCT01165229
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2010-08-02
- Primary completion
- 2015-07-24
- Enrollment
- 14819
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.